<

 
Data updated 2025-06-05 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date20165284.9 (espacenet)  (Federated)  (European Patent Register), 20130605
Patent/reg. no. and dateDK/EP 3730132, 20220504
Publication date20201028
Priority no. and dateUS 201261656451 P, 20120606
EP pub. no. and date EP 3730132 20201028
Effective date
Applicant/ownerNalpropion Pharmaceuticals LLC, 155 Franklin Rd, Suite 450
Brentwood, TN 37027, US
Applicant ref. no.P80383DK01
InventorKLASSEN, Preston, 7762 Lookout Drive
La Jolla, CA 92037, US,
TAYLOR, Kristin, 15023 Palomino Mesa Road
San Diego, CA 92127, US
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/137 (2006.01) , A61K 31/485 (2006.01) , A61K 9/20 (2006.01) , A61P 3/04 (2006.01) , A61P 9/00 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) , G01G 19/414 (2006.01) , G09B 19/00 (2006.01) , G09B 5/06 (2006.01) , G16H 20/10 (2018.01) 
TitleSAMMENSÆTNING TIL ANVENDELSE VED EN FREMGANGSMÅDE TIL BEHANDLING AF OVERVÆGT OG OBESITAS HOS PATIENTER MED HØJ KARDIOVASKULÆR RISIKO
Int. application no.
Int. publication no.
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact